CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_83070368_83070519 | Tlx2 | 150 | 0.836985 | -0.26 | 5.9e-02 | Click! |
chr6_83071355_83071594 | Tlx2 | 1181 | 0.174172 | -0.35 | 9.9e-03 | Click! |
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_16073322_16073836 | 52.50 |
4930444P10Rik |
RIKEN cDNA 4930444P10 gene |
7633 |
0.17 |
chr16_11423409_11423900 | 34.05 |
Snx29 |
sorting nexin 29 |
2946 |
0.31 |
chr1_16073908_16074338 | 29.74 |
4930444P10Rik |
RIKEN cDNA 4930444P10 gene |
7089 |
0.18 |
chr6_87740576_87740855 | 11.82 |
Efcc1 |
EF hand and coiled-coil domain containing 1 |
7906 |
0.09 |
chr6_114659890_114660158 | 11.42 |
Atg7 |
autophagy related 7 |
1960 |
0.4 |
chr11_48855844_48857180 | 10.56 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chrX_136135584_136135889 | 10.39 |
Bex4 |
brain expressed X-linked 4 |
3260 |
0.16 |
chr11_78073909_78074294 | 8.59 |
Mir451b |
microRNA 451b |
860 |
0.24 |
chr15_66825863_66826251 | 8.52 |
Sla |
src-like adaptor |
5589 |
0.21 |
chr9_107971775_107971975 | 8.26 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
3630 |
0.07 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 19.0 | GO:0008380 | RNA splicing(GO:0008380) |
1.4 | 14.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.6 | 12.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.5 | 11.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.8 | 11.4 | GO:0008228 | opsonization(GO:0008228) |
2.1 | 10.7 | GO:0060431 | primary lung bud formation(GO:0060431) |
3.4 | 10.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.9 | 9.2 | GO:0000050 | urea cycle(GO:0000050) |
1.7 | 8.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 8.5 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 67.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 61.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 56.7 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 46.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 37.6 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 34.2 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 31.3 | GO:0005634 | nucleus(GO:0005634) |
0.3 | 25.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 22.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 21.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 50.0 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 21.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 16.8 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 16.2 | GO:0003729 | mRNA binding(GO:0003729) |
0.4 | 15.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 14.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
2.3 | 13.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 13.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.7 | 13.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 12.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 24.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 18.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.3 | 18.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 15.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 12.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 12.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 12.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 12.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 10.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 9.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 28.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 22.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 16.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 15.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 15.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.5 | 14.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.7 | 14.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.8 | 13.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 13.9 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 13.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |